Your session is about to expire
← Back to Search
Behavioral Intervention
Expressive Writing for Young Cancer Patients
N/A
Recruiting
Led By Trisha K. Paul, MD
Research Sponsored by St. Jude Children's Research Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Currently receiving cancer-directed therapy
Aged 15-25
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention interview will occur after the narrative exercise is completed at around 2 months after enrollment, +/- 1 month
Awards & highlights
Study Summary
This trial aims to explore whether writing exercises are beneficial for young people with cancer.
Who is the study for?
This trial is for young people aged 15-25 who are currently being treated for cancer at St. Jude Children's Research Hospital. It aims to see if they're interested in and benefit from a writing exercise designed to help with their experiences.Check my eligibility
What is being tested?
The study tests the impact of creative writing activities on adolescents and young adults with cancer. Participants will engage in writing exercises, and researchers will evaluate how feasible and valuable this narrative medicine intervention is.See study design
What are the potential side effects?
Since the intervention involves writing and interviews, there are no direct medical side effects expected. However, participants may experience emotional or psychological responses related to discussing or reflecting on their personal experiences with cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am currently undergoing treatment for my cancer.
Select...
I am between 15 and 25 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during the narrative exercise, up to 2 months after enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the narrative exercise, up to 2 months after enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intervention acceptability
Number of participants who complete the writing exercise
Number of touchpoints that participants have with the narrative medicine expert/guide
Trial Design
1Treatment groups
Experimental Treatment
Group I: ParticipantsExperimental Treatment2 Interventions
Adolescents and young adults (AYA) patients aged 15-25 years currently receiving cancer-directed therapy at St. Jude Children's Research Hospital
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Writing
2020
N/A
~870
Interview
2019
N/A
~1450
Find a Location
Who is running the clinical trial?
St. Jude Children's Research HospitalLead Sponsor
428 Previous Clinical Trials
5,306,593 Total Patients Enrolled
Trisha K. Paul, MDPrincipal InvestigatorSt. Jude Children's Research Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently undergoing treatment for my cancer.I am between 15 and 25 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this research require participants to meet a certain age threshold?
"These trials are open to those aged between 15 and 25 years old."
Answered by AI
Is it permissible for me to join this medical study?
"In order to be eligible for this trial, cancer patients must fall between the ages of 15 and 25. Currently, this clinical study is seeking 20 participants."
Answered by AI
Are there still opportunities available to join this experiment?
"It seems the research project is not currently accruing patients, as per information provided by clinicaltrials.gov which details its posting on August 1st 2023 and last update July 27th 2023. However, 11 other trials are in need of participants at this time."
Answered by AI
Share this study with friends
Copy Link
Messenger